| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 11.817 | 68.992 | 85.614 | 90.553 | 108.289 | 133.150 | 151.921 | 168.287 |
| Total Income - EUR | - | - | 11.817 | 68.993 | 85.615 | 90.556 | 108.290 | 137.233 | 152.453 | 170.258 |
| Total Expenses - EUR | - | - | 8.156 | 38.996 | 52.553 | 55.119 | 67.830 | 85.261 | 89.719 | 113.288 |
| Gross Profit/Loss - EUR | - | - | 3.661 | 29.997 | 33.062 | 35.437 | 40.460 | 51.973 | 62.733 | 56.970 |
| Net Profit/Loss - EUR | - | - | 3.532 | 29.308 | 32.205 | 34.808 | 39.398 | 50.765 | 61.245 | 52.317 |
| Employees | - | - | 3 | 3 | 3 | 2 | 4 | 3 | 3 | 3 |
Check the financial reports for the company - Erad Neurofam Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 2.284 | 2.762 | 3.514 | 2.227 | 7.851 | 40.453 | 28.386 | 22.322 |
| Current Assets | - | - | 5.253 | 28.609 | 42.860 | 58.230 | 39.312 | 41.384 | 41.971 | 37.731 |
| Inventories | - | - | 0 | 226 | 764 | 0 | 0 | 0 | 0 | 506 |
| Receivables | - | - | 3.767 | 22.685 | 7.085 | 11.809 | 3.199 | 9.787 | 21.901 | 0 |
| Cash | - | - | 1.486 | 5.698 | 35.011 | 46.421 | 36.113 | 31.597 | 20.070 | 37.225 |
| Shareholders Funds | - | - | 3.576 | 26.666 | 32.357 | 55.182 | 40.797 | 60.296 | 61.417 | 52.499 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 3.961 | 4.705 | 14.016 | 5.276 | 6.366 | 19.722 | 16.694 | 11.299 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 1.819 | 1.283 | 748 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Erad Neurofam Srl